Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,299 | -3,956 | -17,984 | -13,520 | -9,355 |
| Depreciation Amortization | 246 | 35 | -1,388 | 312 | 204 |
| Other Working Capital | 619 | -708 | 2,342 | 1,397 | 137 |
| Other Operating Activity | 232 | 126 | 2,364 | 471 | 355 |
| Operating Cash Flow | $-8,202 | $-4,503 | $-14,666 | $-11,340 | $-8,659 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -8 | -118 | -59 | -59 |
| Investing Cash Flow | $-8 | $-8 | $-118 | $-59 | $-59 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 4,000 | 4,000 | 4,000 |
| Other Financing Activity | 0 | 0 | -7 | -7 | -7 |
| Financing Cash Flow | $N/A | $N/A | $3,993 | $3,993 | $3,993 |
| Beginning Cash Position | 26,428 | 26,428 | 37,219 | 37,219 | 37,219 |
| End Cash Position | 18,218 | 21,917 | 26,428 | 29,813 | 32,494 |
| Net Cash Flow | $-8,210 | $-4,511 | $-10,791 | $-7,406 | $-4,725 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,202 | -4,503 | -14,666 | -11,340 | -8,659 |
| Capital Expenditure | -8 | -8 | -118 | -59 | -59 |
| Free Cash Flow | -8,210 | -4,511 | -14,784 | -11,399 | -8,718 |